Patents

IN199821: A process for the preparation of a vaccine against tuberculosis

M. tuberculosis was cultivated in allogeneic (AMTV) and syngeneic (SMTV) macrophages and was killed by Y-irradiation and was used as a vaccine. The AMTV in vivo will preferably be engulfed by dendritic cells (Y-irradiation causes cells to undergo apoptosis and dendritic cells engulf apoptotic cells) and will then activate the mycobacterium reactive naive T cells. Allogeneic macrophages being used for immunization. Dendritic cells are the preferred Antigen Presenting Cells (APC) for Th1 and cytotoxic T cells (CTL), Th1 and CD8+ CTL are principal cells in generating effective and protective immunity against M. tuberculosis.

Filing Date: 28-08-2003

Issue Date: 22-09-2006

Applicant: CSIR-Institute of Microbial Technology (CSIR-IMT), Chandigarh

Patent No: IN199821

Application No: 01372DELNP2003

Inventor(s): Javed Naim Agrewala, Naresh Sharma

IPC Classification: A61K 39/02

Country: India

Related Patents